XClose

UCL News

Home
Menu

AstraZeneca vaccine possibly linked to slight increase of Guillain-Barré syndrome

30 May 2022

“The benefits from these vaccines and drugs are huge and the risk is tiny and there aren’t that many viral vectors you can use, but it’s good that the public are aware of the risks,” said Professor Michael Lunn (UCL Queen Square Institute of Neurology).

Read: Telegraph, More: Mirror